Legarda-Ceballos Ana L, López-Abán Julio, Del Olmo Esther, Escarcena Ricardo, Bustos Luis A, Rojas-Caraballo Jose, Vicente Belén, Fernández-Soto Pedro, San Feliciano Arturo, Muro Antonio
Parasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, University of Salamanca (IBSAL-CIETUS), Avda. Licenciado Méndez Nieto s/n, 37007, Salamanca, Spain.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy (IBSAL-CIETUS), University of Salamanca, 37007, Salamanca, Spain.
Parasit Vectors. 2016 Jun 28;9(1):364. doi: 10.1186/s13071-016-1648-5.
Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice.
The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 μM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days.
In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 μM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %).
These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis.
类圆线虫病是一种广泛存在于热带和亚热带地区的寄生虫病。粪类圆线虫是感染人类的主要物种。伊维菌素是目前的首选药物;然而,糖尿病患者或感染1型嗜T淋巴细胞病毒的患者出现治疗失败的问题,使得鉴定用于替代治疗的新分子成为当务之急。在本研究中,评估了鞘氨醇相关氨基醇和二胺对委内瑞拉类圆线虫第三期幼虫(L3)培养物和小鼠实验性感染的活性。
使用XTT(2,3-双-(2-甲氧基-4-硝基-5-磺基苯基)-2H-四唑-5-甲酰苯胺)测定法和显微镜观察,评估每种化合物在1至350μM浓度范围内对L3的疗效。使用J774.2巨噬细胞系和XTT测定法评估细胞毒性。确定半数致死浓度(LC50)、选择性指数(SI)和构效关系。活性化合物4(2-(乙氨基)十六烷-1-醇)、6(2-(丁氨基)十六烷-1-醇)、17(叔丁基N-(1-氨基十二烷-2-基)氨基甲酸酯)和18(叔丁基N-(1-氨基十六烷-2-基)氨基甲酸酯)进一步针对CD1小鼠的实验性委内瑞拉类圆线虫感染进行评估,测量孤雌生殖雌虫数量和粪便中虫卵数量的减少情况。小鼠感染3000条L3,并以20mg/kg/天的剂量治疗5天。
在对15种氨基醇[月桂基(n = 9);棕榈基(n = 13);硬脂基(n = 15)和醇衍生物]的筛选研究中,棕榈醇链的存在与对L3的最高疗效相关(LC50为31.9 - 39.1μM)。用中等大小的片段如乙基或正丁基对2-氨基进行烷基化显示出最佳的杀幼虫活性。二烷基化并未提高疗效。氨基醇4和6显示出最高的SI(分别为1.5和1.6)。对于二胺衍生物化合物,十六个碳原子的链大小(棕榈酰链,n = 13)以及用中等大小的片段对2-氨基进行烷基化与最高的致死活性相关。二胺17和18中氨基甲酰基的存在产生了高SI(分别为1.7和1.4)。用氨基醇6治疗的感染小鼠孤雌生殖雌虫数量减少(59%),粪便中虫卵数量减少(51%)。
这些结果支持氨基醇和二胺鞘氨醇相关化合物作为开发抗类圆线虫病新的有前景药物的合适原型的潜力。